vs

Side-by-side financial comparison of ACCO BRANDS Corp (ACCO) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

ACCO BRANDS Corp is the larger business by last-quarter revenue ($428.8M vs $220.8M, roughly 1.9× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs 5.0%, a 0.8% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs -4.3%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 9.3%).

ACCO Brands Corporation is an American multinational company. It was created by the merger of ACCO World from Fortune Brands with General Binding Corporation (GBC). As of 2025, its president and CEO is Thomas W. Tedford.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

ACCO vs UTI — Head-to-Head

Bigger by revenue
ACCO
ACCO
1.9× larger
ACCO
$428.8M
$220.8M
UTI
Growing faster (revenue YoY)
UTI
UTI
+13.9% gap
UTI
9.6%
-4.3%
ACCO
Higher net margin
UTI
UTI
0.8% more per $
UTI
5.8%
5.0%
ACCO
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
9.3%
ACCO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ACCO
ACCO
UTI
UTI
Revenue
$428.8M
$220.8M
Net Profit
$21.3M
$12.8M
Gross Margin
33.6%
Operating Margin
9.3%
7.1%
Net Margin
5.0%
5.8%
Revenue YoY
-4.3%
9.6%
Net Profit YoY
3.4%
-42.1%
EPS (diluted)
$0.23
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACCO
ACCO
UTI
UTI
Q4 25
$428.8M
$220.8M
Q3 25
$383.7M
$222.4M
Q2 25
$394.8M
$204.3M
Q1 25
$317.4M
$207.4M
Q4 24
$448.1M
$201.4M
Q3 24
$420.9M
$196.4M
Q2 24
$438.3M
$177.5M
Q1 24
$358.9M
$184.2M
Net Profit
ACCO
ACCO
UTI
UTI
Q4 25
$21.3M
$12.8M
Q3 25
$4.0M
$18.8M
Q2 25
$29.2M
$10.7M
Q1 25
$-13.2M
$11.4M
Q4 24
$20.6M
$22.2M
Q3 24
$9.3M
$18.8M
Q2 24
$-125.2M
$5.0M
Q1 24
$-6.3M
$7.8M
Gross Margin
ACCO
ACCO
UTI
UTI
Q4 25
33.6%
Q3 25
33.0%
Q2 25
32.9%
Q1 25
31.4%
Q4 24
34.7%
Q3 24
32.5%
Q2 24
34.8%
Q1 24
30.8%
Operating Margin
ACCO
ACCO
UTI
UTI
Q4 25
9.3%
7.1%
Q3 25
6.8%
11.2%
Q2 25
8.4%
6.9%
Q1 25
-2.1%
8.1%
Q4 24
9.4%
13.6%
Q3 24
6.2%
13.3%
Q2 24
-25.4%
4.2%
Q1 24
1.6%
6.1%
Net Margin
ACCO
ACCO
UTI
UTI
Q4 25
5.0%
5.8%
Q3 25
1.0%
8.4%
Q2 25
7.4%
5.2%
Q1 25
-4.2%
5.5%
Q4 24
4.6%
11.0%
Q3 24
2.2%
9.6%
Q2 24
-28.6%
2.8%
Q1 24
-1.8%
4.2%
EPS (diluted)
ACCO
ACCO
UTI
UTI
Q4 25
$0.23
$0.23
Q3 25
$0.04
$0.33
Q2 25
$0.31
$0.19
Q1 25
$-0.14
$0.21
Q4 24
$0.21
$0.40
Q3 24
$0.09
$0.35
Q2 24
$-1.29
$0.09
Q1 24
$-0.07
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACCO
ACCO
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$162.8M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$664.6M
$335.9M
Total Assets
$2.3B
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACCO
ACCO
UTI
UTI
Q4 25
$162.8M
Q3 25
$169.1M
Q2 25
$70.7M
Q1 25
$96.0M
Q4 24
$172.0M
Q3 24
$161.9M
Q2 24
$115.5M
Q1 24
$116.1M
Total Debt
ACCO
ACCO
UTI
UTI
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Q1 24
$141.9M
Stockholders' Equity
ACCO
ACCO
UTI
UTI
Q4 25
$664.6M
$335.9M
Q3 25
$644.0M
$328.1M
Q2 25
$637.3M
$306.8M
Q1 25
$606.1M
$293.9M
Q4 24
$606.1M
$280.0M
Q3 24
$615.5M
$260.2M
Q2 24
$617.1M
$239.4M
Q1 24
$758.5M
$232.6M
Total Assets
ACCO
ACCO
UTI
UTI
Q4 25
$2.3B
$834.0M
Q3 25
$2.3B
$826.1M
Q2 25
$2.4B
$740.8M
Q1 25
$2.3B
$720.4M
Q4 24
$2.2B
$753.8M
Q3 24
$2.4B
$744.6M
Q2 24
$2.4B
$706.0M
Q1 24
$2.5B
$702.1M
Debt / Equity
ACCO
ACCO
UTI
UTI
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACCO
ACCO
UTI
UTI
Operating Cash FlowLast quarter
$30.6M
$3.1M
Free Cash FlowOCF − Capex
$-19.2M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
10.1%
Cash ConversionOCF / Net Profit
1.44×
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACCO
ACCO
UTI
UTI
Q4 25
$30.6M
$3.1M
Q3 25
$71.5M
$57.1M
Q2 25
$-38.9M
$18.1M
Q1 25
$5.5M
$-789.0K
Q4 24
$52.7M
$23.0M
Q3 24
$92.9M
$67.5M
Q2 24
$-25.6M
$10.0M
Q1 24
$28.2M
$-2.5M
Free Cash Flow
ACCO
ACCO
UTI
UTI
Q4 25
$-19.2M
Q3 25
$40.6M
Q2 25
$6.8M
Q1 25
$-11.7M
Q4 24
$19.6M
Q3 24
$60.0M
Q2 24
$3.0M
Q1 24
$-8.4M
FCF Margin
ACCO
ACCO
UTI
UTI
Q4 25
-8.7%
Q3 25
18.3%
Q2 25
3.4%
Q1 25
-5.7%
Q4 24
9.7%
Q3 24
30.6%
Q2 24
1.7%
Q1 24
-4.6%
Capex Intensity
ACCO
ACCO
UTI
UTI
Q4 25
10.1%
Q3 25
7.4%
Q2 25
5.5%
Q1 25
5.3%
Q4 24
1.7%
Q3 24
3.8%
Q2 24
4.0%
Q1 24
3.2%
Cash Conversion
ACCO
ACCO
UTI
UTI
Q4 25
1.44×
0.24×
Q3 25
17.88×
3.04×
Q2 25
-1.33×
1.69×
Q1 25
-0.07×
Q4 24
2.56×
1.04×
Q3 24
9.99×
3.58×
Q2 24
2.01×
Q1 24
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACCO
ACCO

Transferred At Point In Time$421.6M98%
Transferred Over Time$7.2M2%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons